US regulators have approved a haemophilia drug that will cost $3.5m per patient, making it the world’s most expensive medicine, according to Business Insider India
Published in Dawn, The Business and Finance Weekly, December 5th, 2022
US regulators have approved a haemophilia drug that will cost $3.5m per patient, making it the world’s most expensive medicine, according to Business Insider India
Published in Dawn, The Business and Finance Weekly, December 5th, 2022
Dear visitor, the comments section is undergoing an overhaul and will return soon.